Intuitive Surgical, Inc. recalls da Vinci SP, SP Access Port Kit, Large Incision
The stated reason: Access Port System tray may develop cracks potentially resulting in a sterility breach.
Intuitive Surgical, Inc. began a medical device recall on December 15, 2025 whose reported distribution included Ohio. FDA
What the record shows
recalled da Vinci SP, SP Access Port Kit, Large Incision Reference Numbers:430073 (2.7-4cm,SP1098, Box) & 430075 (2.7-7cm,SP1098,Box) beginning December 15, 2025, in a medical device recall whose distribution included Ohio. FDA graded it Class II — use may cause temporary or medically reversible health consequences. Quantity affected: 41,526 units. The recall is listed as ongoing. FDA
Context
By the numbers
- Date of record: December 15, 2025 FDA
- Recall number: Z-1096-2026 FDA
- Recalls in this action: 1 FDA
- Recalling firm: Intuitive Surgical, Inc. FDA
- Product: da Vinci SP, SP Access Port Kit, Large Incision Reference Numbers:430073 (2.7-4cm,SP1098, Box) & 430075… FDA
- Reason for recall: Access Port System tray may develop cracks potentially resulting in a sterility breach. FDA
Assembled mechanically from the source filing and The Lantern's own record database — no AI-written prose. Every figure above appears verbatim in the cited record, which is linked on this page. FDA
Sources
The source filing
| Recall number | Z-1096-2026 |
|---|---|
| Recalls in this action | 1 |
| Recalling firm | Intuitive Surgical, Inc. |
| Product | da Vinci SP, SP Access Port Kit, Large Incision Reference Numbers:430073 (2.7-4cm,SP1098, Box) & 430075 (2.7-7cm,SP1098,Box) |
| Reason for recall | Access Port System tray may develop cracks potentially resulting in a sterility breach. |
| Classification | Class II — use may cause temporary or medically reversible health consequences |
| Recall type | medical device |
| Quantity | 41,526 units |
| Status | Ongoing |
| Voluntary or mandated | Voluntary: Firm initiated |
| Initiated | 20251215 |
| Reported | 20260121 |
| Distribution | Worldwide - US Nationwide distribution including in the states of Alabama, Arizona, California, Colorado, Connecticut, Florida, Georgia, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Nevada, New Hampshire, New Jersey, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, South Dakota, Tenn |
| Firm location | Sunnyvale, CA, United States |
Published by U.S. Food and Drug Administration (openFDA). This is the agency's public filing as The Lantern received it, shown with its fields named in plain English.